Clinical Trial Update: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial examining perioperative lenvatinib with pembrolizumab in locally advanced nonmetastatic clear cell renal cell carcinoma; results have been posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Emory University | Conditions: Kidney Cancer, Stage III Renal Cell Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-20